BUTALBITAL, ASPIRIN AND CAFFEINE Drug Patent Profile
✉ Email this page to a colleague
When do Butalbital, Aspirin And Caffeine patents expire, and what generic alternatives are available?
Butalbital, Aspirin And Caffeine is a drug marketed by Lgm Pharma, Mpp Pharma, Watson Labs, Actavis Elizabeth, Fosun Pharma, Halsey, Hikma Intl Pharms, Ivax Pharms, Puracap Pharm, Quantum Pharmics, and Strides Pharma. and is included in twelve NDAs.
The generic ingredient in BUTALBITAL, ASPIRIN AND CAFFEINE is aspirin; butalbital; caffeine. There are twenty-two drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the aspirin; butalbital; caffeine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BUTALBITAL, ASPIRIN AND CAFFEINE?
- What are the global sales for BUTALBITAL, ASPIRIN AND CAFFEINE?
- What is Average Wholesale Price for BUTALBITAL, ASPIRIN AND CAFFEINE?
Summary for BUTALBITAL, ASPIRIN AND CAFFEINE
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 12 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| DailyMed Link: | BUTALBITAL, ASPIRIN AND CAFFEINE at DailyMed |
Pharmacology for BUTALBITAL, ASPIRIN AND CAFFEINE
US Patents and Regulatory Information for BUTALBITAL, ASPIRIN AND CAFFEINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lgm Pharma | BUTALBITAL, ASPIRIN AND CAFFEINE | aspirin; butalbital; caffeine | CAPSULE;ORAL | 205230-001 | Oct 18, 2021 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma Intl Pharms | BUTALBITAL, ASPIRIN AND CAFFEINE | aspirin; butalbital; caffeine | TABLET;ORAL | 086162-002 | Feb 16, 1984 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Actavis Elizabeth | BUTALBITAL, ASPIRIN AND CAFFEINE | aspirin; butalbital; caffeine | TABLET;ORAL | 086710-002 | Aug 23, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
